Connection

Richard Drake to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

This is a "connection" page, showing publications Richard Drake has written about Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization.
  1. Optimization of Multiple Glycosidase and Chemical Stabilization Strategies for N-Glycan Isomer Detection by Mass Spectrometry Imaging in Formalin-Fixed, Paraffin-Embedded Tissues. Methods Mol Biol. 2021; 2271:303-316.
    View in: PubMed
    Score: 0.595
  2. Array-Based N-Glycan Profiling of Cells in Culture. Methods Mol Biol. 2021; 2271:331-342.
    View in: PubMed
    Score: 0.595
  3. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow. J Am Soc Mass Spectrom. 2020 Dec 02; 31(12):2511-2520.
    View in: PubMed
    Score: 0.580
  4. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry. J Mass Spectrom. 2020 Apr; 55(4):e4490.
    View in: PubMed
    Score: 0.557
  5. Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI-Imaging Mass Spectrometry. Proteomics Clin Appl. 2019 01; 13(1):e1700152.
    View in: PubMed
    Score: 0.516
  6. In Situ Imaging of Tryptic Peptides by MALDI Imaging Mass Spectrometry Using Fresh-Frozen or Formalin-Fixed, Paraffin-Embedded Tissue. Curr Protoc Protein Sci. 2018 11; 94(1):e65.
    View in: PubMed
    Score: 0.505
  7. In Situ Imaging of N-Glycans by MALDI Imaging Mass Spectrometry of Fresh or Formalin-Fixed Paraffin-Embedded Tissue. Curr Protoc Protein Sci. 2018 11; 94(1):e68.
    View in: PubMed
    Score: 0.503
  8. MALDI Imaging Mass Spectrometry of N-glycans and Tryptic Peptides from the Same Formalin-Fixed, Paraffin-Embedded Tissue Section. Methods Mol Biol. 2018; 1788:225-241.
    View in: PubMed
    Score: 0.483
  9. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues. Adv Exp Med Biol. 2018; 1104:59-76.
    View in: PubMed
    Score: 0.483
  10. Mapping Extracellular Matrix Proteins in Formalin-Fixed, Paraffin-Embedded Tissues by MALDI Imaging Mass Spectrometry. J Proteome Res. 2018 01 05; 17(1):635-646.
    View in: PubMed
    Score: 0.481
  11. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues. Adv Cancer Res. 2017; 134:85-116.
    View in: PubMed
    Score: 0.450
  12. Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow. Bioanalysis. 2015; 7(20):2611-9.
    View in: PubMed
    Score: 0.416
  13. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Biomolecules. 2015 Oct 15; 5(4):2554-72.
    View in: PubMed
    Score: 0.415
  14. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal Chem. 2014 Aug 19; 86(16):8303-11.
    View in: PubMed
    Score: 0.382
  15. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal Chem. 2013 Oct 15; 85(20):9799-806.
    View in: PubMed
    Score: 0.360
  16. Characterization of a Staphylococcus aureus USA300 protein signature using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Med Microbiol. 2012 May; 61(Pt 5):640-644.
    View in: PubMed
    Score: 0.321
  17. Pathogen identification using mass spectrometry in the clinical microbiology laboratory. J Mass Spectrom. 2011 Dec; 46(12):1223-32.
    View in: PubMed
    Score: 0.317
  18. Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF. J Proteome Res. 2009 Sep; 8(9):4182-92.
    View in: PubMed
    Score: 0.271
  19. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009 May; 208(5):970-8; discussion 978-80.
    View in: PubMed
    Score: 0.263
  20. Proteomic approach to breast cancer. Cancer Control. 2007 Oct; 14(4):360-8.
    View in: PubMed
    Score: 0.237
  21. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics. 2006 Oct; 5(10):1957-67.
    View in: PubMed
    Score: 0.217
  22. Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer. Sci Rep. 2022 Dec 02; 12(1):20801.
    View in: PubMed
    Score: 0.170
  23. Evaluation of Therapeutic Collagen-Based Biomaterials in the Infarcted Mouse Heart by Extracellular Matrix Targeted MALDI Imaging Mass Spectrometry. J Am Soc Mass Spectrom. 2021 Dec 01; 32(12):2746-2754.
    View in: PubMed
    Score: 0.158
  24. Applications and continued evolution of glycan imaging mass spectrometry. Mass Spectrom Rev. 2023 03; 42(2):674-705.
    View in: PubMed
    Score: 0.155
  25. Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells. Clin Lab Med. 2021 06; 41(2):247-266.
    View in: PubMed
    Score: 0.152
  26. Multiplexed imaging mass spectrometry of the extracellular matrix using serial enzyme digests from formalin-fixed paraffin-embedded tissue sections. Anal Bioanal Chem. 2021 Apr; 413(10):2709-2719.
    View in: PubMed
    Score: 0.148
  27. Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry. Prostate. 2020 09; 80(13):1071-1086.
    View in: PubMed
    Score: 0.144
  28. Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry. J Mass Spectrom. 2020 Apr; 55(4):e4450.
    View in: PubMed
    Score: 0.140
  29. Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery. Curr Protoc Protein Sci. 2019 12; 98(1):e99.
    View in: PubMed
    Score: 0.138
  30. A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging. Anal Chem. 2019 07 02; 91(13):8429-8435.
    View in: PubMed
    Score: 0.134
  31. Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues. Proteomics Clin Appl. 2019 01; 13(1):e1800014.
    View in: PubMed
    Score: 0.130
  32. Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular Pathology. Am J Pathol. 2018 08; 188(8):1779-1793.
    View in: PubMed
    Score: 0.125
  33. Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass Spectrometry. SLAS Discov. 2017 12; 22(10):1218-1228.
    View in: PubMed
    Score: 0.117
  34. Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve. Biochim Biophys Acta Proteins Proteom. 2017 Jul; 1865(7):927-935.
    View in: PubMed
    Score: 0.114
  35. Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section. Anal Chem. 2016 08 02; 88(15):7745-53.
    View in: PubMed
    Score: 0.109
  36. Linkage-Specific in Situ Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues. Anal Chem. 2016 06 07; 88(11):5904-13.
    View in: PubMed
    Score: 0.108
  37. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. PLoS One. 2014; 9(9):e106255.
    View in: PubMed
    Score: 0.096
  38. MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 2014 Apr; 14(7-8):924-35.
    View in: PubMed
    Score: 0.093
  39. Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen. Chem Commun (Camb). 2011 Oct 07; 47(37):10338-40.
    View in: PubMed
    Score: 0.078
  40. MALDI tissue imaging: from biomarker discovery to clinical applications. Anal Bioanal Chem. 2011 Jul; 401(1):17-27.
    View in: PubMed
    Score: 0.076
  41. Challenges to developing proteomic-based breast cancer diagnostics. OMICS. 2011 May; 15(5):251-9.
    View in: PubMed
    Score: 0.075
  42. Enhancement in MALDI-TOF MS analysis of the low molecular weight human serum proteome. J Mass Spectrom. 2011 Jan; 46(1):85-9.
    View in: PubMed
    Score: 0.074
  43. High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol. 2009 Nov; 47(11):3732-4.
    View in: PubMed
    Score: 0.068
  44. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res. 2009 Sep 01; 15(17):5541-51.
    View in: PubMed
    Score: 0.068
  45. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. J Proteome Res. 2009 Feb; 8(2):620-30.
    View in: PubMed
    Score: 0.065
  46. Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease. J Proteomics. 2009 Aug 20; 72(6):907-17.
    View in: PubMed
    Score: 0.065
  47. Precision enhancement of MALDI-TOF MS using high resolution peak detection and label-free alignment. Proteomics. 2008 Apr; 8(8):1530-8.
    View in: PubMed
    Score: 0.061
  48. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope. 2008 Jan; 118(1):61-8.
    View in: PubMed
    Score: 0.060
  49. Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling. Rapid Commun Mass Spectrom. 2006; 20(11):1670-8.
    View in: PubMed
    Score: 0.053
  50. Proteomics for biodefense applications: progress and opportunities. Expert Rev Proteomics. 2005 Apr; 2(2):203-13.
    View in: PubMed
    Score: 0.050
  51. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology. 2005 Mar; 41(3):634-42.
    View in: PubMed
    Score: 0.050
  52. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Expert Rev Mol Diagn. 2005 Jan; 5(1):93-100.
    View in: PubMed
    Score: 0.049
  53. In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues. EMBO Mol Med. 2022 11 08; 14(11):e16029.
    View in: PubMed
    Score: 0.042
  54. Novel Combined Enzymatic Approach to Analyze Nonsialylated N-Linked Glycans through MALDI Imaging Mass Spectrometry. J Proteome Res. 2022 08 05; 21(8):1930-1938.
    View in: PubMed
    Score: 0.041
  55. GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis. Front Immunol. 2022; 13:797460.
    View in: PubMed
    Score: 0.040
  56. Mass Spectrometry Imaging of N-Linked Glycans in a Formalin-Fixed Paraffin-Embedded Human Prostate by Infrared Matrix-Assisted Laser Desorption Electrospray Ionization. J Proteome Res. 2022 01 07; 21(1):243-249.
    View in: PubMed
    Score: 0.040
  57. Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain. J Neuroinflammation. 2021 May 16; 18(1):116.
    View in: PubMed
    Score: 0.038
  58. Spatial N-glycomics of the human aortic valve in development and pediatric endstage congenital aortic valve stenosis. J Mol Cell Cardiol. 2021 05; 154:6-20.
    View in: PubMed
    Score: 0.037
  59. Multiplexed Imaging Mass Spectrometry of Histological Staining, N-Glycan and Extracellular Matrix from One Tissue Section: A Tool for Fibrosis Research. Methods Mol Biol. 2021; 2350:313-329.
    View in: PubMed
    Score: 0.037
  60. New Enzymatic Approach to Distinguish Fucosylation Isomers of N-Linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry. J Proteome Res. 2020 08 07; 19(8):2989-2996.
    View in: PubMed
    Score: 0.036
  61. Core-Fucosylated Tetra-Antennary N-Glycan Containing A Single N-Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer. Int J Mol Sci. 2019 May 23; 20(10).
    View in: PubMed
    Score: 0.033
  62. Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities. Am J Pathol. 2017 Apr; 187(4):864-883.
    View in: PubMed
    Score: 0.029
  63. Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male Mice. Cancer Prev Res (Phila). 2016 06; 9(6):466-75.
    View in: PubMed
    Score: 0.027
  64. LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. J Pharmacol Exp Ther. 2013 Jan; 344(1):167-78.
    View in: PubMed
    Score: 0.021
  65. Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis. Biochemistry. 2006 Feb 21; 45(7):2322-32.
    View in: PubMed
    Score: 0.013
  66. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers. 2003-2004; 19(4-5):229-38.
    View in: PubMed
    Score: 0.011
  67. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. II. Enzymatic characterization and identification of the catalytic subunit. J Biol Chem. 1996 Dec 06; 271(49):31446-51.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.